why choose us

First received: September 27, 2023

Clinical Trial: A Study to Test Whether BI 456906 Helps People Living With Overweight or Obesity Who Also Have Diabetes to Lose Weight

Study Status: Completed

Recruit Status: RECRUITING

Condition: Obesity

Study Type: INTERVENTIONAL


Official Title: A Phase 3, Randomised, Double-blind, Parallel-group, 76-week, Efficacy and Safety Study of BI 456906 Administered Subcutaneously Compared With Placebo in Participants With Overweight or Obesity and Ty

Brief Summary: This study is open to adults who are at least 18 years old and have a body mass index of 27 kg/m² or more.People can take part if they have type 2 diabetes and if they are currently being treated only with diet and exercise or with specific diabetes medications.Only people who have previously not managed to lose weight by changing their diet can participate.The purpose of this study is to find out whether a medicine called survodutide (BI 456906) helps people living with overweight or obesity who also have…

Read more